COLL

Collegium Pharmaceutical, Inc.

33.83 USD
+0.22 (+0.65%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Collegium Pharmaceutical, Inc. stock is up 6.82% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 July’s closed higher than June.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. develops and commercializes medicines for pain management. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone.